期刊文献+

阿托伐他汀治疗合并糖尿病的高脂血症30例疗效观察 被引量:1

Effect of Atorpin on Fluvastatin on Hyperlipidemia in Diabetic Role of Lipidlowering
下载PDF
导出
摘要 目的:观察阿托伐他汀对糖尿病高脂血症的降脂作用。方法:合并糖尿病的高脂血症患者30例,用阿托伐他汀10 mg,每晚1次,连服2周和4周后各复查血脂1次,进行疗效分析。结果:4周后,血清低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)和甘油三酯(TG)水平均有下降,以LDL-C降低。结论:阿托伐他汀降血脂对合并糖尿病的高脂血症疗效快速、确切。 Objective:To explore the effect of atorpin on fluvastatin on hyperlipidemia in diabetic role of lipidlowering. Methods:30 petients with Hyperlipidemia with diabetes mellitus, With atorvastatin 10 mgper night and even served two weeks and four weeks after the review of lipid 1 for efficacy analysis. Results : After four weeks, all levels of Serum low-density lipoprotein cholesterol, total cholesterol and triglyeride were decreased, and LDL-C was the most obvious. Conclusion : Hypolipidemic effect of atorvastatin on combined hyperlipidemia diabetes fast and precise.
出处 《广州医学院学报》 2009年第4期64-66,共3页 Academic Journal of Guangzhou Medical College
关键词 阿托伐他汀 高脂血症 糖尿病 atorvastatin hyperlipoidemia diabetes
  • 相关文献

参考文献7

  • 1徐成斌.冠心病防治在调脂领域的某些进展与动向[J].心血管病学进展,2002,23(1):1-5. 被引量:34
  • 2Lea AP, Mc Tavish D. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias [ J ]. Drugs, 1997,53 (5):828-47.
  • 3Jones P,Kafonek S,Laurora I. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin,lovastalin andfluvas -tatin in patients with hypercholesterolemia (the CURVES study) [ J].Am J Cardiol, 1998,81 (5) :582-7.
  • 4Huse DM, Russell Mw, Miller JD, et al. Cost-effectiveness of statins[ J]. Am J Cardiol, 1998,82( 11 ) :1357-63.
  • 5Hilleman DE, Heineman SM, Foral PA. Pharmacoeconomie assessment of HMG-CoA reductase inhibtor therapy: an analysis based on the CURVES study [ J ]. Pharmacotherapy, 2000,20( 7 ) :819-22.
  • 6Crisby M, Nordin-Fredriksson G,Shah PK,et al. Pravastatin treatment increases collagen content and decreases lipid content,inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization [ J ]. Circulation ,2001,103 ( 7 ) :926-33.
  • 7王增武,满荣海,史平,武阳丰,陆宗良.他汀类药物预防心血管病事件的非调脂机制[J].心血管病学进展,2003,24(1):1-4. 被引量:63

二级参考文献16

  • 1[1]Scandinavian Simvastatin Survival Study Group. Randomise d trial of choles terol lowering in 4 444 patients with coronary heart disease: the Scandinavian Survival Study(4S)[J]. Lancet,1994,344:1383-1389.
  • 2[2]Sacks FM,Pfeffer MA,Moye LA,et al. The effect of pravastatin on coro nary events after myocardial infarction in patients with average cholesterol evels. Cholesterol and Recurrent Events Trial Ingestigarors[ J ]. N Engl J Med, 1996,335: 1001-1009.
  • 3[3]The Long-Term Intervention with Pravastatin in Ischemie Heart Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of ini tial cholesterol Levels[J]. N Engl J Med,1998,339:1349-1357.
  • 4[4]Shepherd J,Cobbe SM,Ford 1,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scot[and coronary prevention Study Group[J ]. N Engl J Med, 1995,333: 130l-1307.
  • 5[5]Downs JR,Clearfield M,Weis S,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels Re sults of AFCAPS/Tex CAPS[J]. JAMA,1998,279:1615-1622.
  • 6[6]The lipid research clinics coronary primary prevention trial results. I reduc tion in incidence of coronary heart disease[J]. JAMA. 1984,251: 351-364
  • 7[7]NCEP(National Cholesterol Education Program). Guidelines of the second adult treatment panel( ATP I )[J]. JAMA,1993,267:3015-3023.
  • 8[8]The Post Coronary Artery Bypass Graft Trial Invesugators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts[J ]. N Engl J Med,1997,336:153-162.
  • 9[9]Pitt B,Waters D,Brown WV,et al. Aggressive lipid lowering therapy compared with angioplasty in stable coronary artery disease[J]. N Engl J Med,1999,341:70-76.
  • 10[10]Davignon J. Pleiotropic effects: facts and fiction XⅢ International Symposium on Atherosclerosls[R]. Sweden Stockholm: 2000-1 25~29.

共引文献93

同被引文献4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部